CYCS and neoplasm: Fisetin has been reported to interfere with the loss of Ψm leading to apoptosis and inhibition of tumor growth, accumulation of excess ROS causing nuclear DNA damage, disruption of Ψm, and release of cytochrome c into the cytosol.